1992 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 others, Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, P., Cazzaniga, M., Lorusso, V., Latorre, A., Campanella, G., Ciccarese, M., Accettura, C., Pisconti, S., Rinaldi, A., Brunetti, C., Raffaele, M., Coltelli, L., Spazzapan, S., Fratino, L., Petrucelli, L. & 1 others, Biganzoli, L., Jun 2019, In : Oncologist. 24, 6, p. e232-e240

Research output: Contribution to journalArticle

Open Access
2018

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, M., Cazzaniga, M., Lorusso, V., Latorre, A., Campanella, G., Ciccarese, M., Accettura, C., Pisconti, S., Rinaldi, A., Brunetti, C., Raffaele, M., Coltelli, L., Spazzapan, S., Fratino, L., Petrucelli, L. & 1 others, Biganzoli, L., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

2017

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience

Ciccarese, M., Fabi, A., Moscetti, L., Cazzaniga, M. E., Petrucelli, L., Forcignanò, R., Lupo, L. I., De Matteis, E., Chiuri, V. E., Cairo, G., Febbraro, A., Giordano, G., Giampaglia, M., Bilancia, D., La Verde, N., Maiello, E., Morritti, M., Giotta, F., Lorusso, V., Latorre, A. & 5 others, Scavelli, C., Romito, S., Cusmai, A., Palmiotti, G. & Surico, G., Jun 1 2017, In : Breast Cancer Research and Treatment. 163, 3, p. 587-594 8 p.

Research output: Contribution to journalArticle

Efficacy and safety of eribulin in taxane-refractory patients in the 'real world'

Lorusso, V., Cinieri, S., Latorre, A., Porcu, L., Del Mastro, L., Puglisi, F. & Barni, S., May 1 2017, In : Future Oncology. 13, 11, p. 971-978 8 p.

Research output: Contribution to journalArticle

2016

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study

Arpino, G., Michelotti, A., Truini, M., Montemurro, F., Russo, S., Palumbo, R., Zamagni, C., Latorre, A. C., Bruzzese, D., Riccardi, F., De Laurentiis, M., Beano, A., Biganzoli, L., Zaniboni, A., Laudadio, L., Malagoli, M., Bilancia, D., Schettini, F., Giuliano, M., Cazzaniga, M. & 1 others, De Placido, S., Mar 1 2016, In : Journal of Cancer Research and Clinical Oncology. 142, 3, p. 669-678 10 p.

Research output: Contribution to journalArticle

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study

Arpino, G., Michelotti, A., Truini, M., Montemurro, F., Russo, S., Palumbo, R., Zamagni, C., Latorre, A. C., Bruzzese, D., Riccardi, F., De Laurentiis, M., Beano, A., Biganzoli, L., Zaniboni, A., Laudadio, L., Malagoli, M., Bilancia, D., Schettini, F., Giuliano, M., Cazzaniga, M. & 1 others, De Placido, S., Mar 1 2016, In : Journal of Cancer Research and Clinical Oncology. 142, 3, p. 669-678 10 p.

Research output: Contribution to journalArticle

Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study

Arpino, G., Michelotti, A., Truini, M., Montemurro, F., Russo, S., Palumbo, R., Zamagni, C., Latorre, A., Bruzzese, D., Riccardi, F., De Laurentiis, M., Beano, A., Biganzoli, L., Zaniboni, A., Laudadio, L., Malagoli, M., Bilancia, D., Schettini, F., Giuliano, M., Cazzaniga, M. E. & 1 others, De Placido, S., Mar 1 2016, In : Journal of Cancer Research and Clinical Oncology. 142, 3, p. 669-678 10 p.

Research output: Contribution to journalArticle

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics

Petroni, S., Caldarola, L., Scamarcio, R., Giotta, F., Latorre, A., Mangia, A. & Simone, G., Nov 1 2016, In : Oncology Letters. 12, 5, p. 3115-3122 8 p.

Research output: Contribution to journalArticle

2013

Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement

Giotta, F., Latorre, A., Cramarossa, A., Simone, G., Florio, C., Oliva, S. & Lorusso, V., Nov 2013, In : Tumori. 99, 6

Research output: Contribution to journalArticle

2011

A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: A gruppo oncologico italia meridionale study

Vici, P., Giotta, F., Di Lauro, L., Sergi, D., Vizza, E., Mariani, L., Latorre, A., Pizzuti, L., D'Amico, C., Giannarelli, D. & Colucci, G., Dec 2011, In : Oncology. 81, 3-4, p. 230-236 7 p.

Research output: Contribution to journalArticle

2007

Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β-tubulins

Tommasi, S., Mangia, A., Lacalamita, R., Bellizzi, A., Fedele, V., Chiriatti, A., Thomssen, C., Kendzierski, N., Latorre, A., Lorusso, V., Schittulli, F., Zito, F., Kavallaris, M. & Paradiso, A., May 15 2007, In : International Journal of Cancer. 120, 10, p. 2078-2085 8 p.

Research output: Contribution to journalArticle

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: A phase II multicentric study

Giotta, F., Lorusso, V., Maiello, E., Filippelli, G., Valerio, M. R., Caruso, M., Verderame, F., Latorre, A. & Colucci, G., Jun 2007, In : Annals of Oncology. 18, SUPPL. 6

Research output: Contribution to journalArticle

2006

Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale)

Lorusso, V., Spada, M., Giampaglia, M., Misino, A., Calabrese, R., Latorre, A., Monticelli, G., Guida, M., Sambiasi, D. & Colucci, G., Jun 2006, In : Annals of Oncology. 17, SUPPL. 7

Research output: Contribution to journalArticle

2005

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

Paradiso, A., Mangia, A., Chiriatti, A., Tommasi, S., Zito, A., Latorre, A., Schittulli, F. & Lorusso, V., May 2005, In : Annals of Oncology. 16, SUPPL. 4

Research output: Contribution to journalArticle

2003

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin

Catino, A., Crucitta, E., Latorre, A., Sambiasi, D., Calabrese, P. & Lorusso, V., Jan 2003, In : Oncology Reports. 10, 1, p. 163-167 5 p.

Research output: Contribution to journalArticle

A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer

Lorusso, V., Crucitta, E., Silvestris, N., Guida, M., Misino, A., Latorre, A. & De Lena, M., 2003, In : Clinical Breast Cancer. 4, 2, p. 138-141 4 p.

Research output: Contribution to journalArticle

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

Lorusso, V., Crucitta, E., Silvestris, N., Catino, A., Caporusso, L., Mazzei, A., Guida, M., Latorre, A., Sambiasi, D., D'Amico, C., Schittulli, F., Calabrese, P. & De Lena, M., Feb 24 2003, In : British Journal of Cancer. 88, 4, p. 491-495 5 p.

Research output: Contribution to journalArticle

2002

Epithelial ovarian cancer: second and third line chemotherapy (review).

Latorre, A., De Lena, M., Catino, A., Crucitta, E., Sambiasi, D., Guida, M., Misino, A. & Lorusso, V., Jul 2002, In : International Journal of Oncology. 21, 1

Research output: Contribution to journalArticle

2001

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

De Lena, M., Lorusso, V., Latorre, A., Fanizza, G., Gargano, G., Caporusso, L., Guida, M., Catino, A., Crucitta, E., Sambiasi, D. & Mazzei, A., 2001, In : European Journal of Cancer. 37, 3, p. 364-368 5 p.

Research output: Contribution to journalArticle

2000

High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: A phase I-II study

De Lena, M., Latorre, A., Calabrese, P., Catino, A., Lorusso, V., Mazzei, A. & Aloe, A., 2000, In : Journal of Chemotherapy. 12, 4, p. 367-373 7 p.

Research output: Contribution to journalArticle

1999

Mitoxantrone, l-leucovorin and 5-fluorouracil: An effective and well tolerated first-line treatment for advanced breast cancer

Lorusso, V., Mancarella, S., Catino, A., Brandi, M., Paradiso, A., Latorre, A., Mastria, A., De Mitrio, A., Guida, M. & De Lena, M., Jan 1999, In : Tumori. 85, 1, p. 60-64 5 p.

Research output: Contribution to journalArticle

1997

Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum

De Lena, M., Lorusso, V., Bottalico, C., Brandi, M., De Mitrio, A., Catino, A., Guida, M., Latorre, A., Leone, B., Vallejo, C. & Gargano, G., Oct 1997, In : Journal of Clinical Oncology. 15, 10, p. 3208-3213 6 p.

Research output: Contribution to journalArticle

Subcutaneous recombinant interleukin-2 plus α interferon and vinblastine in metastatic renal cell carcinoma: A phase II study

Guida, M., Latorre, A., Selvaggi, P. P., Ditonno, P., Lorusso, V., Mastria, A. & De Lena, M., Mar 1997, In : International Journal of Oncology. 10, 3, p. 487-491 5 p.

Research output: Contribution to journalArticle

1996

Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)

Lorusso, V., Carpagnano, F., Di Rienzo, G., Catino, A., Cisternino, M. L., Guida, M., Brandi, M., Latorre, A., Parisi, S., Ricco, R. & De Lena, M., Apr 1996, In : International Journal of Oncology. 8, 4, p. 675-680 6 p.

Research output: Contribution to journalArticle

Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

Guida, M., Latorre, A., Mastria, A. & De Lena, M., Apr 1996, In : European Journal of Cancer. 32, 4, p. 730-733 4 p.

Research output: Contribution to journalArticle

1995

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: Biological effects and clinical implications

Guida, M., Abbate, I., Musci, M. D., Casamassima, A., Latorre, A., Lorusso, V., Correale, M. & De Lena, M., 1995, In : Cancer Biotherapy. 10, 3, p. 195-203 9 p.

Research output: Contribution to journalArticle

1993

Effects of subcutaneous recombinant IL-2 on humoral immunity in advanced cancer patients

Casamassima, A., Guida, M., Latorre, A., Abbate, I., Triantafillou, V., Musci, M. & De Lena, M., 1993, In : International Journal of Oncology. 3, 2, p. 171-176 6 p.

Research output: Contribution to journalArticle

Evaluation of phagocytic activity in neoplastic patients treated with subcutaneous recombinant IL-2

Abbate, I., Guida, M., Musci, M. D., Casamassima, A., Latorre, A., Addabbo, L., Dragone, C. D., Cattedra, M., Correale, M. & De Lena, M., 1993, In : International Journal of Oncology. 3, 4, p. 603-606 4 p.

Research output: Contribution to journalArticle

1992

INTERLEUCHINA-2: CARATTERISTICHE BIOLOGICHE E POTENZIALITA TERAPEUTICHE IN ONCOLOGIA

Translated title of the contribution: Interleukin-2: Biological characteristics and therapeutic potential in oncologyAddabbo, L., Casamassima, A., Guida, M., Abbate, I., Correale, M., Latorre, A., Mastria, A., Lorusso, V. & De Lena, M., 1992, In : Folia Oncologica. 15, 1, p. 21-26 6 p.

Research output: Contribution to journalArticle